- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
7
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
7 companies
GSK
Market Cap: UK£76.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.26
7D
-2.9%
1Y
37.3%
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.57
7D
-1.6%
1Y
-29.6%
Oxford Nanopore Technologies
Market Cap: UK£1.1b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.17
7D
1.5%
1Y
-2.8%
Animalcare Group
Market Cap: UK£228.9m
Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.
ANCR
UK£3.32
7D
0%
1Y
20.1%
Faron Pharmaceuticals Oy
Market Cap: UK£97.6m
Operates as a clinical stage drug discovery and development company.
FARN
UK£0.43
7D
-3.3%
1Y
-78.5%
Bioventix
Market Cap: UK£95.4m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£17.45
7D
7.4%
1Y
-32.9%
OptiBiotix Health
Market Cap: UK£6.1m
A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.
OPTI
UK£0.059
7D
-4.0%
1Y
-50.4%